Health and Healthcare

Fate Therapeutics : FATE

All Fate Therapeutics Articles

20 Articles

Chris Lange | Apr 6, 2020 at 10:39 AM EDT

What Wedbush Is Watching in Biotechs Amid Coronavirus Crisis

In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here,…

Jon C. Ogg | Mar 4, 2020 at 9:39 AM EST

Top Analyst Upgrades and Downgrades: Altria, Beyond Meat, Chevron, Chipotle, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm, Target and More

Wednesday's top analyst upgrades, downgrades and initiations included Altria, Beyond Meat, Chevron, Chipotle Mexican Grill, Epizyme, FedEx, Home Depot, Mattel,…

Chris Lange | Dec 12, 2019 at 12:05 PM EST

Wedbush’s Top Picks After ASH Annual Meeting

The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this…

Chris Lange | Dec 9, 2019 at 11:50 AM EST

Why Fate Therapeutics Is One of ASH’s Biggest Winners

Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer…

Jon C. Ogg | Oct 1, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More

Tuesday's top analyst upgrades, downgrades and initiations included Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron Technology, PG&E, Snap and…

1 2

Fate Therapeutics : FATE

All Fate Therapeutics Articles

What Wedbush Is Watching in Biotechs Amid Coronavirus Crisis

Top Analyst Upgrades and Downgrades: Altria, Beyond Meat, Chevron, Chipotle, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm, Target and More

Wedbush’s Top Picks After ASH Annual Meeting

Why Fate Therapeutics Is One of ASH’s Biggest Winners

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More

“They’re Going to Accuse You of Having Stolen From Your Parents”: George Kamel to Caller Hiding a $50,000 CD From Her Siblings

SLV vs. SIVR: Same Silver, Lower Fee, So Which Physical Silver ETF Should You Actually Hold?

SIL vs. SILJ: Silver Miners and Senior Stability or Junior Leverage After the $120 Break and $60 Consolidation Test?

"They're Going to Accuse You of Having Stolen From Your Parents": George Kamel to Caller Hiding a $50,000 CD From Her Siblings

$400 a Month Starting at 30 Beats $900 a Month Starting at 45. Most People Wait.

“They’re Going to Accuse You of Having Stolen From Your Parents”: George Kamel to Caller Hiding a $50,000 CD From Her Siblings

$400 a Month Starting at 30 Beats $900 a Month Starting at 45. Most People Wait.

Fate Therapeutics : FATE

All Fate Therapeutics Articles

What Wedbush Is Watching in Biotechs Amid Coronavirus Crisis

Top Analyst Upgrades and Downgrades: Altria, Beyond Meat, Chevron, Chipotle, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm, Target and More

Wedbush’s Top Picks After ASH Annual Meeting

Why Fate Therapeutics Is One of ASH’s Biggest Winners

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More

“They’re Going to Accuse You of Having Stolen From Your Parents”: George Kamel to Caller Hiding a $50,000 CD From Her Siblings

SLV vs. SIVR: Same Silver, Lower Fee, So Which Physical Silver ETF Should You Actually Hold?

SIL vs. SILJ: Silver Miners and Senior Stability or Junior Leverage After the $120 Break and $60 Consolidation Test?

Featured Reads

"They're Going to Accuse You of Having Stolen From Your Parents": George Kamel to Caller Hiding a $50,000 CD From Her Siblings

$400 a Month Starting at 30 Beats $900 a Month Starting at 45. Most People Wait.